title: [Hepatic failure due to nevirapine treatment for HIV infection].
abstract: Two cases of hepatic failure due to nevirapine treatment are reported. One patient erroneously took double dosing of nevirapine, while the other patient did not attend the scheduled laboratory control two weeks after the initiation of nevirapine treatment. In spite of maximal conservative treatment, this patient died five days after admission. These cases emphasise the importance of giving patients thorough instructions as well as doing clinical and laboratory monitoring of patients receiving highly active antiretroviral treatment (HAART).
authors.affiliation: H:S Rigshospitalet, AIDS-laboratoriet, Epidemiafdelingen.
authors.forename: Helene
authors.initials: H
authors.lastname: Mens
authors.forename: Terese L
authors.initials: TL
authors.lastname: Katzenstein
mesh_terms: D000328:Adult; D019380:Anti-HIV Agents / Q000008:administration & dosage / Q000009:adverse effects*; D023241:Antiretroviral Therapy, Highly Active; D017809:Fatal Outcome; D005260:Female; D006679:HIV Seropositivity / Q000188:drug therapy; D006801:Humans; D017114:Liver Failure, Acute / Q000139:chemically induced*; D008297:Male; D008508:Medication Errors; D008875:Middle Aged; D019829:Nevirapine / Q000008:administration & dosage / Q000009:adverse effects*; D010353:Patient Education as Topic
chemical_list: D019380:Anti-HIV Agents; D019829:Nevirapine